slides · global inventory
Resolution
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 42,534
Current window 30,901-30,930
Pages 1,418
Rows per page 30
Beat
30,901-30,930 of 42,534
47
The slide includes a section for Management team and a section for Board of Directors, with headshots and titles for each individual, followed by a logo grid of affiliated organizations.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
48
The slide uses a table-based timeline structure to map drug candidates (SPY001-004) against expected clinical milestones.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
49
The slide uses a custom bar chart visualization within a table to show market cap ranges (Min, IPO, Today, Max).Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
50
The table maps historical M&A deal values to Spyre's internal pipeline milestones.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
51
Aeglea BioTherapeutics | Investor Presentation Deck | 56 slidesAeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
52
The slide highlights the partnership with Paragon Therapeutics, detailing its founding, team size, operational capacity, program count, and the spin-out of Apogee Therapeutics.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
53
The slide uses a series of icons to represent different scientific methodologies.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
54
The central graphic is an antibody structure inside a pentagon, representing the five optimization pillars.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
55
The slide uses a split-screen diagram to contrast physiological affinity vs high affinity in the context of FcRn-mediated antibody recycling.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
56
The slide uses a scatter plot to show correlation between Cyno and Human half-lives, and bar charts to compare ADA (Anti-Drug Antibody) rates.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
15
Disney | Investor Presentation Deck | 27 slidesDisney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Action1 hit
16
The slide uses emotional imagery (father and daughter) to anchor financial metrics.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Action1 hit
17
Includes Disney Vacation Club logo in top right corner.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Action1 hit
18
The slide serves as a visual announcement for a new property development.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Action1 hit
19
The slide features an architectural rendering of the property with branding elements.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Action1 hit
20
Disney | Investor Presentation Deck | 27 slidesDisney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Action1 hit
21
The slide provides a massive scale metric for Disney's international park reach, with a disclaimer regarding the inclusion of Tokyo Disney Resort.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Action1 hit
22
The chart includes a break in the x-axis between FY19 and FY22.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Action1 hit
23
The image features a family at a Disney park, reinforcing the brand context.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Action1 hit
24
The slide uses a high-quality lifestyle image to evoke emotional connection to the brand.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Action1 hit
25
The slide uses a high-impact visual of Disney characters to reinforce the 'rebound' theme.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Action1 hit
26
Metrics compare FY18 (pre-renovation) to FY22.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Action1 hit
27
The slide uses a thematic 30th-anniversary visual style.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Action1 hit
10
Uses analogy to travel booking platforms (Amadeus/Sabre and Booking.com/Expedia) to explain the business model.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
07
Includes a scatter plot of vintage vs market multiple and a waterfall-style bridge for proceeds.Hipgnosis Songs Fund | Results Presentation Deck | 22 slides · Hipgnosis Songs Fund
Activist deck Investor relations Beat · Solution (Provide relief)Loop · Before After1 hit
08
The slide uses a comparison table to justify a portfolio disposal strategy by showing improved quality metrics in the remaining assets.Hipgnosis Songs Fund | Results Presentation Deck | 22 slides · Hipgnosis Songs Fund
Activist deck Investor relations Beat · Solution (Provide relief)Loop · Before After1 hit
09
Hipgnosis Songs Fund | Results Presentation Deck | 22 slidesHipgnosis Songs Fund | Results Presentation Deck | 22 slides · Hipgnosis Songs Fund
Activist deck Investor relations Beat · Solution (Provide relief)Loop · Before After1 hit
46
The slide uses a process-like structure to map the platform pillars to specific product outputs.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
47
Includes technical diagrams of the drug molecule, comparative histology, and survival curves.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
48
Includes two sets of charts: tumor volume line graphs and survival curves. References specific dosing schedules and study parameters.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit